Baidu
map

感染指南

订阅

MedSci主页 / 所有栏目 / 感染指南

抗菌药物药代动力学/药效学理论临床应用专家共识

2018-06-20 中国医药教育协会感染疾病专业委员会 中化结核和呼吸杂志.2018,41(6):409-446.

抗菌药物药代动力学药效学临床应用

在目前细菌耐药迅速变迁、新抗菌药物研发严重滞后的情况下，药代动力学/药效学（PK/PD）理论的临床应用是发挥现有抗菌药物治疗潜力的可靠策略之一，务必给予足够的重视。近年来关于抗菌药物PK/PD的研究进展迅速，研究发现重症感染患者与健康人的PK/PD数据明显不同，为此国外相关指南做出了相应修改感染性疾病的诊治需要多学科的协作，临床医师需要掌握足够的临床药理学知识指导临床治疗，但目前我国尚缺少完整统一

中文标题：

抗菌药物药代动力学/药效学理论临床应用专家共识

发布机构：

中国医药教育协会感染疾病专业委员会

发布日期：

2018-06-20

简要介绍：

在目前细菌耐药迅速变迁、新抗菌药物研发严重滞后的情况下，药代动力学/药效学（PK/PD）理论的临床应用是发挥现有抗菌药物治疗潜力的可靠策略之一，务必给予足够的重视。近年来关于抗菌药物PK/PD的研究进展迅速，研究发现重症感染患者与健康人的PK/PD数据明显不同，为此国外相关指南做出了相应修改感染性疾病的诊治需要多学科的协作，临床医师需要掌握足够的临床药理学知识指导临床治疗，但目前我国尚缺少完整统一的关于抗菌药物PK/PD的专家共识。 

拓展指南：与抗菌相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=抗菌药物药代动力学/药效学理论临床应用专家共识)] GetToolGuiderByIdResponse(projectId=1, id=b359f1c001606872, title=抗菌药物药代动力学/药效学理论临床应用专家共识, enTitle=, guiderFrom=中化结核和呼吸杂志.2018,41(6):409-446., authorId=null, author=, summary=在目前细菌耐药迅速变迁、新抗菌药物研发严重滞后的情况下，药代动力学/药效学（PK/PD）理论的临床应用是发挥现有抗菌药物治疗潜力的可靠策略之一，务必给予足够的重视。近年来关于抗菌药物PK/PD的研究进展迅速，研究发现重症感染患者与健康人的PK/PD数据明显不同，为此国外相关指南做出了相应修改感染性疾病的诊治需要多学科的协作，临床医师需要掌握足够的临床药理学知识指导临床治疗，但目前我国尚缺少完整统一, cover=, journalId=null, articlesId=null, associationId=1353, associationName=中国医药教育协会感染疾病专业委员会, associationIntro=, copyright=0, guiderPublishedTime=Wed Jun 20 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>在目前细菌耐药迅速变迁、新抗菌药物研发严重滞后的情况下，药代动力学/药效学（PK/PD）理论的临床应用是发挥现有抗菌药物治疗潜力的可靠策略之一，务必给予足够的重视。近年来关于抗菌药物PK/PD的研究进展迅速，研究发现重症感染患者与健康人的PK/PD数据明显不同，为此国外相关指南做出了相应修改感染性疾病的诊治需要多学科的协作，临床医师需要掌握足够的临床药理学知识指导临床治疗，但目前我国尚缺少完整统一的关于抗菌药物PK/PD的专家共识。 </div> <div><br> </div> 拓展指南：<strong>与<font color=red>抗菌</font>相关指南：</strong><br><ul><li><a href="//m.sandwebs.com/guideline/show_article.do?id=f1e8b1c0015a3264" title="《创伤后抗菌药物预防使用专家共识》解读" target=_blank>《创伤后抗菌药物预防使用专家共识》解读</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=29b5a1c00153e98c" title="氟喹诺酮类抗菌药物在儿童应用中的专家共识" target=_blank>氟喹诺酮类抗菌药物在儿童应用中的专家共识</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=65d301c001383136" title="广泛耐药革兰阴性菌感染的实验诊断、抗菌治疗及医院感染控制：中国专家共识" target=_blank>广泛耐药革兰阴性菌感染的实验诊断、抗菌治疗及医院感染控制：中国专家共识</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=a51561c00135e81f" title="抗菌药物超说明书用法专家共识" target=_blank>抗菌药物超说明书用法专家共识</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=c1e731c001355559" title="2017 NICE指南：抗菌药物管理（NG.63）" target=_blank>2017 NICE指南：抗菌药物管理（NG.63）</a></li> 更多信息请点击：<a href="//m.sandwebs.com/guideline/list.do?q=%E6%8A%97%E8%8F%8C" target=_blank>有关抗菌更多指南</a></ul>, tagList=[TagDto(tagId=5642, tagName=抗菌药物), TagDto(tagId=17730, tagName=药代动力学), TagDto(tagId=27276, tagName=药效学), TagDto(tagId=611, tagName=临床应用)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8844, appHits=508, showAppHits=0, pcHits=5157, showPcHits=4778, likes=122, shares=29, comments=8, approvalStatus=1, publishedTime=Sun Jun 24 23:12:46 CST 2018, publishedTimeString=2018-06-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Jun 24 23:12:46 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 22:38:36 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=抗菌药物药代动力学/药效学理论临床应用专家共识)])
抗菌药物药代动力学/药效学理论临床应用专家共识
下载请点击：
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=349621, encodeId=ca643496215f, content=学习了，非常有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AicRibibwhnWAW33YRia7y5sicGOoEzFQ4Jzmt3N9mtq1lZOXghRysQ33pzibKOXyQUuTpZSGsEeyicy1zX75nRB1yuaQ/132, createdBy=5e942360447, createdName=foxv3羽翼, createdTime=Wed Oct 17 08:50:00 CST 2018, time=2018-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327930, encodeId=e4ff32e93054, content=好东西!很多很好!值得好好研究!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/31/c5cd65bc1b2b43a9370a16b370993572.jpg, createdBy=baa92155751, createdName=小不忍则, createdTime=Fri Jun 29 09:27:22 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326866, encodeId=bf3332686630, content=好好文章学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Mon Jun 25 09:41:46 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326772, encodeId=5a83326e7285, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Mon Jun 25 01:00:55 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326764, encodeId=9705326e645b, content=学习了很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Mon Jun 25 00:30:16 CST 2018, time=2018-06-25, status=1, ipAttribution=)]
    2018-10-17 foxv3羽翼

    学习了，非常有用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=349621, encodeId=ca643496215f, content=学习了，非常有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AicRibibwhnWAW33YRia7y5sicGOoEzFQ4Jzmt3N9mtq1lZOXghRysQ33pzibKOXyQUuTpZSGsEeyicy1zX75nRB1yuaQ/132, createdBy=5e942360447, createdName=foxv3羽翼, createdTime=Wed Oct 17 08:50:00 CST 2018, time=2018-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327930, encodeId=e4ff32e93054, content=好东西!很多很好!值得好好研究!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/31/c5cd65bc1b2b43a9370a16b370993572.jpg, createdBy=baa92155751, createdName=小不忍则, createdTime=Fri Jun 29 09:27:22 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326866, encodeId=bf3332686630, content=好好文章学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Mon Jun 25 09:41:46 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326772, encodeId=5a83326e7285, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Mon Jun 25 01:00:55 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326764, encodeId=9705326e645b, content=学习了很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Mon Jun 25 00:30:16 CST 2018, time=2018-06-25, status=1, ipAttribution=)]
    2018-06-29 小不忍则

    好东西!很多很好!值得好好研究!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=349621, encodeId=ca643496215f, content=学习了，非常有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AicRibibwhnWAW33YRia7y5sicGOoEzFQ4Jzmt3N9mtq1lZOXghRysQ33pzibKOXyQUuTpZSGsEeyicy1zX75nRB1yuaQ/132, createdBy=5e942360447, createdName=foxv3羽翼, createdTime=Wed Oct 17 08:50:00 CST 2018, time=2018-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327930, encodeId=e4ff32e93054, content=好东西!很多很好!值得好好研究!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/31/c5cd65bc1b2b43a9370a16b370993572.jpg, createdBy=baa92155751, createdName=小不忍则, createdTime=Fri Jun 29 09:27:22 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326866, encodeId=bf3332686630, content=好好文章学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Mon Jun 25 09:41:46 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326772, encodeId=5a83326e7285, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Mon Jun 25 01:00:55 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326764, encodeId=9705326e645b, content=学习了很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Mon Jun 25 00:30:16 CST 2018, time=2018-06-25, status=1, ipAttribution=)]
    2018-06-25 139****5926

    好好文章学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=349621, encodeId=ca643496215f, content=学习了，非常有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AicRibibwhnWAW33YRia7y5sicGOoEzFQ4Jzmt3N9mtq1lZOXghRysQ33pzibKOXyQUuTpZSGsEeyicy1zX75nRB1yuaQ/132, createdBy=5e942360447, createdName=foxv3羽翼, createdTime=Wed Oct 17 08:50:00 CST 2018, time=2018-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327930, encodeId=e4ff32e93054, content=好东西!很多很好!值得好好研究!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/31/c5cd65bc1b2b43a9370a16b370993572.jpg, createdBy=baa92155751, createdName=小不忍则, createdTime=Fri Jun 29 09:27:22 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326866, encodeId=bf3332686630, content=好好文章学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Mon Jun 25 09:41:46 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326772, encodeId=5a83326e7285, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Mon Jun 25 01:00:55 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326764, encodeId=9705326e645b, content=学习了很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Mon Jun 25 00:30:16 CST 2018, time=2018-06-25, status=1, ipAttribution=)]
    2018-06-25 phoebeyan520

    学习了.谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=349621, encodeId=ca643496215f, content=学习了，非常有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AicRibibwhnWAW33YRia7y5sicGOoEzFQ4Jzmt3N9mtq1lZOXghRysQ33pzibKOXyQUuTpZSGsEeyicy1zX75nRB1yuaQ/132, createdBy=5e942360447, createdName=foxv3羽翼, createdTime=Wed Oct 17 08:50:00 CST 2018, time=2018-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327930, encodeId=e4ff32e93054, content=好东西!很多很好!值得好好研究!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/31/c5cd65bc1b2b43a9370a16b370993572.jpg, createdBy=baa92155751, createdName=小不忍则, createdTime=Fri Jun 29 09:27:22 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326866, encodeId=bf3332686630, content=好好文章学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Mon Jun 25 09:41:46 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326772, encodeId=5a83326e7285, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Mon Jun 25 01:00:55 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326764, encodeId=9705326e645b, content=学习了很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Mon Jun 25 00:30:16 CST 2018, time=2018-06-25, status=1, ipAttribution=)]
    2018-06-25 飛歌

    学习了很有用

    0

相关指南

《创伤后抗菌药物预防使用专家共识》解读

暂未更新 · 2017-12-30

2015 NICE指南：抗菌药物管理（NG.15）

暂未更新 · 2015-08-18

2016 BSAC/EWMA意见书：创伤护理中抗菌药物管理

英国抗菌化疗学会(BSAC,British Society for Antimicrobial Chemotherapy) · 2016-07-25

Baidu
map
Baidu
map
Baidu
map